C07H 19/167
With ribosyl as the saccharide radical
Official title: with ribosyl as the saccharide radical
C07H19/167 (With ribosyl as the saccharide radical) appears on 242 US grants and 387 published applications in this corpus.
Search patents in C07H- Granted patents
- 242
- Published applications
- 387
- Assignees
- 249
- Inventors
- 949
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 4 | 0 |
| 2000 | 2 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 1 | 3 |
| 2005 | 2 | 3 |
| 2006 | 1 | 11 |
| 2007 | 2 | 12 |
| 2008 | 4 | 6 |
| 2009 | 9 | 18 |
| 2010 | 7 | 16 |
| 2011 | 7 | 20 |
| 2012 | 14 | 17 |
| 2013 | 13 | 20 |
| 2014 | 14 | 19 |
| 2015 | 17 | 13 |
| 2016 | 18 | 32 |
| 2017 | 12 | 14 |
| 2018 | 8 | 14 |
| 2019 | 19 | 15 |
| 2020 | 10 | 18 |
| 2021 | 19 | 23 |
| 2022 | 10 | 23 |
| 2023 | 11 | 29 |
| 2024 | 11 | 24 |
| 2025 | 19 | 19 |
| 2026 | 8 | 17 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Nucleoside analogs and use thereof in therapeutic treatment4 Aug 2026US 12,698,305 B2Cornell University
- Adenosine A3 receptor agonists, preparation methods and uses thereof16 Jun 2026US 12,655,174 B2Zhejiang Vimgreen Pharmaceuticals, Ltd.
- Synthesis of oligonucleotides and related compounds9 Jun 2026US 12,649,761 B2Janssen BioPharma, Inc.
- Broad spectrum anti-cancer compounds19 May 2026US 12,630,527 B2The Regents of the University of California
- Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereof10 Mar 2026US 12,569,511 B2Alnylam Pharmaceuticals, Inc.
- Prmt inhibitor compounds and the uses thereof8 Oct 2026US 2026/0306527 A1Purdue Research Foundation
- Non-covalent dimer cation of purine/pyrimidine and amino acid, salt thereof, preparation method therefor, and use thereof13 Aug 2026US 2026/0234153 A1Suzhou Protonation Chain Biotechnology Co., Ltd
- Patatin-like phospholipase domain containing 3 (pnpla3) irna compositions and methods of use thereof30 Jul 2026US 2026/0216228 A1Alnylam Pharmaceuticals, Inc.
- Heterocyclic Compounds as ENT Inhibitors and Compounds for Use in the Treatment of Cancers2 Jul 2026US 2026/0184712 A1iTeos Belgium SA
- Methods of synthesizing a targeting ligand-conjugated nucleotide phosphoramidite2 Jul 2026US 2026/0184737 A1Eli Lilly and Company
Most cited
By later US patents
- Method for deuteration of a heterocyclic ring304US 7,517,990 B2Wako Pure Chemical Industries, Ltd. · 2009
- 2'-O-modified nucleosides and phosphoramidites144US 5,914,396 AIsis Pharmaceuticals, Inc. · 1999
- Antiviral nucleoside derivatives119US 6,846,810 B2Roche Palo Alto LLC · 2005
- Method for sequencing DNA and RNA by synthesis106US 7,544,794 B12009
- Alternative nucleic acid molecules and uses thereof81US 10,286,086 B2ModernaTX, Inc. · 2019